Cellularline S.p.A.

MIL:CELL.MI

2.78 (EUR) • At close April 22, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q22017 Q1
Revenue 40.83131.75690.82844.24667.8230.21242.31940.76754.55823.32970.86834.33839.70716.63667.91934.11736.62120.04185.15237.95555.28820.63340.50440.5046.416.4151.60600
Cost of Revenue 27.89322.85760.93425.3249.9319.8523.97427.35938.9614.2244.80417.96429.4269.89642.79918.75827.63711.78250.52219.50434.80811.53719.45419.4543.713.715.4050.0650.065
Gross Profit 12.9388.89929.89418.92617.8910.36218.34513.40815.5989.10926.06416.37410.2816.7425.1215.3598.9848.25934.6318.45120.489.09621.0521.052.72.746.201-0.065-0.065
Gross Profit Ratio 0.3170.280.3290.4280.2640.3430.4330.3290.2860.390.3680.4770.2590.4050.370.450.2450.4120.4070.4860.370.4410.520.520.4210.4210.89500
Reseach & Development Expenses 001.3140.5790.57901.3750.5750000.5730.573000002.680000.2520.25200000
General & Administrative Expenses 07.199-13.90617.1316.9026.686-52.4755.9576.2756.0246.0995.6645.7455.7256.1786.255.0985.3675.2376.6543.5175.0033.4483.4482.7962.79611.91700
Selling & Marketing Expenses 07.336-5.62614.4697.1636.967-0.20910.1115.3317.3247.947.0195.8285.5476.3196.5914.5665.3476.1397.2996.1365.7866.5736.5730.910.9145.58800
SG&A 11.11411.34221.80531.620.92813.653-52.67966.06821.10413.34819.76612.68316.19811.27217.86812.84114.64210.71418.66413.95317.60110.78910.02110.0213.7063.70645.08500
Other Expenses 00-0.5860.269-0.32700.6160.37-0.1210-0.1310-0.0850000000000000000
Operating Expenses 11.11411.34222.39114.73421.25513.31-21.63450.53621.22512.84219.89712.78916.28311.41217.86812.31814.64210.71418.66411.86417.60110.6686.7516.7513.743.7430.9850.0690.069
Operating Income 1.824-2.4437.5034.787-3.365-3.291-34.8333.288-5.627-4.2396.1673.691-6.002-4.5327.2522.518-5.658-2.45515.9664.4982.879-1.69311.02911.029-1.006-1.00625.692-0.163-0.163
Operating Income Ratio 0.045-0.0770.0830.108-0.05-0.109-0.8230.081-0.103-0.1820.0870.107-0.151-0.2720.1070.074-0.155-0.1220.1880.1190.052-0.0820.2720.272-0.157-0.1570.49800
Total Other Income Expenses Net -0.064-0.6760.818-0.886-0.966-0.3930.0350.805-38.4840.561-6.584-0.034-0.259-1.152-4.1820.396-0.1530.5821.6412.578-0.523-0.1570.7860.7862.2432.243-0.3210.0370.037
Income Before Tax 1.76-3.1198.3213.901-4.331-3.684-34.7984.093-44.111-3.678-0.4173.657-6.261-5.6843.072.914-5.811-1.87317.6077.0762.356-1.8511.81511.8151.2371.23725.371-0.126-0.126
Income Before Tax Ratio 0.043-0.0980.0920.088-0.064-0.122-0.8220.1-0.809-0.158-0.0060.107-0.158-0.3420.0450.085-0.159-0.0930.2070.1860.043-0.090.2920.2920.1930.1930.49200
Income Tax Expense 0.488-0.5550.950.195-0.2951.2550.3081.141-1.11.0510.2061.1-2.9161.742-14.7510.851-1.545-0.1752.0930.411-0.220.2832.0352.0355.1735.1735.07500
Net Income 1.272-2.5647.6313.706-4.036-2.429-35.1072.952-43.011-2.627-0.6212.557-3.225-3.94217.8212.063-3.921-1.69815.6346.6662.575-1.5679.789.786.416.4120.296-0.126-0.126
Net Income Ratio 0.031-0.0810.0840.084-0.06-0.08-0.830.072-0.788-0.113-0.0090.074-0.081-0.2370.2620.06-0.107-0.0850.1840.1760.047-0.0760.2410.241110.39300
EPS 0.059-0.120.360.17-0.19-0.11-1.630-2.040-0.0290.097-0.1500.820-0.18-0.0770.7200.1200.470.470.450.450.02800
EPS Diluted 0.059-0.120.360.17-0.19-0.11-1.630-2.040-0.0290.097-0.1500.820-0.18-0.0770.7200.1200.470.470.450.450.02800
EBITDA 5.8850.7514.4458.5323.098-0.2533.834-31.5050.448-1.25512.3617.647-0.329-1.7413.1785.699-0.7150.08221.2246.897.3310.67712.93612.936-0.657-0.65726.284-0.065-0.065
EBITDA Ratio 0.1440.0240.1590.1930.046-0.0080.091-0.7730.008-0.0540.1740.223-0.008-0.1050.1940.167-0.020.0040.2490.1820.1330.0330.3190.319-0.103-0.1030.50900